While TNF-α inhibitors have been proven to be effective in the majority of psoriasis patients, various cutaneous adverse reactions have been reported, such as erythema, vasculitis, edema, bullous lesions, and lichen planus-like dermatitis [56]. The gene discussed is TNF; the disease is psoriasis.